These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11835913)

  • 21. The prognostic value of IL-8 for cardiac events and restenosis in patients with coronary heart diseases after percutaneous coronary intervention.
    Qi X; Li S; Li J
    Jpn Heart J; 2003 Sep; 44(5):623-32. PubMed ID: 14587644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention.
    Kato R; Momiyama Y; Ohmori R; Tanaka N; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
    Circ J; 2009 Jan; 73(1):152-7. PubMed ID: 19023151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention].
    Luo YS; Qian JY; Zhang L; Ma JY; Huang D; Fan B; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Feb; 38(2):126-30. PubMed ID: 20398557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.
    Okmen E; Cam N; Sanli A; Unal S; Tartan Z; Vural M
    Angiology; 2006; 57(2):161-9. PubMed ID: 16518523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.
    Biasucci LM; Liuzzo G; Fantuzzi G; Caligiuri G; Rebuzzi AG; Ginnetti F; Dinarello CA; Maseri A
    Circulation; 1999 Apr; 99(16):2079-84. PubMed ID: 10217645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
    Haverkate F; Thompson SG; Pyke SD; Gallimore JR; Pepys MB
    Lancet; 1997 Feb; 349(9050):462-6. PubMed ID: 9040576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous transluminal coronary angioplasty of the "culprit lesion" for management of unstable angina pectoris in patients with multivessel coronary artery disease.
    Wohlgelernter D; Cleman M; Highman HA; Zaret BL
    Am J Cardiol; 1986 Sep; 58(6):460-4. PubMed ID: 2944366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.
    Liuzzo G; Buffon A; Biasucci LM; Gallimore JR; Caligiuri G; Vitelli A; Altamura S; Ciliberto G; Rebuzzi AG; Crea F; Pepys MB; Maseri A
    Circulation; 1998 Dec; 98(22):2370-6. PubMed ID: 9832480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention.
    Rahel BM; Visseren FL; Suttorp MJ; Plokker TH; Kelder JC; de Jongh BM; Diepersloot RJ; Verkooyen RP; Bouter KP
    Am Heart J; 2004 Oct; 148(4):670-5. PubMed ID: 15459599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of early percutaneous coronary intervention in patients with Braunwald III-B type unstable angina pectoris].
    Nozaki K; Nakao K; Horiuchi K; Kasanuki H; Honda T
    J Cardiol; 2003 Jun; 41(6):263-70. PubMed ID: 12845880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty.
    Wöhrle J; Grebe OC; Nusser T; Al-Khayer E; Schaible S; Kochs M; Hombach V; Höher M
    Circulation; 2003 Apr; 107(14):1840-3. PubMed ID: 12682003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS).
    Lee CH; de Feyter P; Serruys PW; Saia F; Lemos PA; Goedhart D; Soares PR; Umans VA; Ciccone M; Cortellaro M
    Heart; 2004 Oct; 90(10):1156-61. PubMed ID: 15367512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical outcomes according to presentation of angina pectoris versus acute myocardial infarction in patients who underwent a percutaneous coronary intervention with a drug-eluting stent.
    Seo SM; Kim TH; Koh YS; Her SH; Shin DI; Park HJ; Kim PJ; Park CS; Lee JM; Kim DB; Kim HY; Chang K; Yoo KD; Jeon DS; Chung WS; Seung KB;
    Coron Artery Dis; 2016 Mar; 27(2):143-50. PubMed ID: 26693807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels.
    Saleh N; Braunschweig F; Jensen J; Tornvall P
    Am J Cardiol; 2006 Mar; 97(6):830-4. PubMed ID: 16516584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
    Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
    JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeat percutaneous coronary angioplasty; clinical and angiographic follow-up in patients with stable or unstable angina pectoris.
    Bauters C; Lablanche JM; McFadden EP; Leroy F; Bertrand ME
    Eur Heart J; 1993 Feb; 14(2):235-9. PubMed ID: 8449200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina.
    Goldberg A; Zinder O; Zdorovyak A; Diamond E; Lischinsky S; Gruberg L; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2003 Nov; 146(5):819-23. PubMed ID: 14597930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different patterns of interleukin-6 and von Willebrand factor antigen changes after coronary stenting in unstable versus stable angina.
    Spaziani D; De Servi S; Morelli B; D'Urbano M; Vandoni P; Mariani G; Passoni F; Cafiero F
    Ital Heart J; 2002 Oct; 3(10):593-7. PubMed ID: 12478817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
    Duygu H; Turkoglu C; Kirilmaz B; Turk U
    J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.